MODERN POSSIBILITIES OF THERAPY OF TYPE 2 DIABETES MELLITUS PATIENTS. EFFECTIVENESS AND CARDIOSAFETY OF ALOGLIPTIN FROM THE POINT OF VIEW OF EVIDENCE-BASED MEDICINE by A. S. Ametov, E. V. Doskina

Subjects: Get full text

Ten-year follow-up of sitagliptin treatment in patients with type 2 diabetes mellitus by Sachiko Hattori

Subjects: “…Dipeptidyl peptidase 4 inhibitor (DPP4i)…”
Get full text

Dipeptidyl Peptidase-4 inhibitors use in type II diabetic patients in a tertiary hospital by Woh Yon Mak, Jivanraj R. Nagarajah, Hannah Abdul Halim, Anitha Ramadas, Zulsairi Mohd Pauzi, Lay Ting Pee, Nirmala Jagan

Subjects: “…dipeptidyl peptidase 4 inhibitors (dpp4-i)…”
Get full text

The effects of dipeptidyl peptidase-4 inhibitors on cardiac structure and function using cardiac magnetic resonance: a meta-analysis of clinical studies by Haipeng Wang, Siyi Guo, Shuo Gu, Chunyu Li, Fei Wang, Junyu Zhao, Junyu Zhao

Subjects: “…dipeptidyl peptidase-4 inhibitors(DPP4i)…”
Get full text

Changes in HbA1c and weight, and treatment persistence, over the 18 months following initiation of second-line therapy in patients with type 2 diabetes: results from the United Kin... by John Wilding, Thomas Godec, Kamlesh Khunti, Stuart Pocock, Robin Fox, Liam Smeeth, Per Clauson, Peter Fenici, Niklas Hammar, Jesús Medina

Subjects: “…Dipeptidyl peptidase-4 inhibitor (DPP-4 inhibitor)…”
Get full text

Real-world characteristics, modern antidiabetic treatment patterns, and comorbidities of patients with type 2 diabetes in central and Eastern Europe: retrospective cross-sectional... by Martin Prázný, Lyudmila Suplotova, Janusz Gumprecht, Zdravko Kamenov, Tibor Fülöp, Alexey Medvedchikov, Doron Rosenzweig, Milos Aleksandric

Subjects: “…Dipeptidyl peptidase-4 inhibitors (DPP4i)…”
Get full text